NCT00533481已完成2 期
Efficacy of MK0557 in Combination With Sibutramine or Orlistat (0557-015)(COMPLETED)
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 497
研究概览
简要总结
Study medicine will be given alone, or in combination with either sibutramine or orlistat, to obese subjects to compare the effect on body weight over a six month period.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Factorial
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Men and women between the ages of 18-65 who are considered obese (have a body mass index between 30 and 43)
排除标准
- •Subject has high blood pressure or is taking any high blood pressure medicine
- •History of psychiatric disorder, stroke, or heart disease
研究者
相似试验
已完成
3 期
Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian PopulationObesityNCT00677391Abbott103
已完成
4 期
Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) PatientsObstructive Sleep ApneaObesityHypertensionNCT00729963Laval University45
Unknown
3 期
Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese PatientsObesityNCT00941382Laboratorios Silanes S.A. de C.V.60
Unknown
4 期
The Effect of Weight Loss on Anti-Müllerian Hormone Levels in Women With Polycystic Ovary Syndrome (PCOS)Polycystic Ovaries SyndromeObesityNCT01475019Aristotle University Of Thessaloniki200
已完成
2 期
Metformin Versus Orlistat in Obese Polycystic Ovary Syndrome (PCOS) PatientsObesityNCT01003483Yazd Research & Clinical Center for Infertility80